PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: evidence from patients in Northwestern China

Por Wu, Kai-Jie, Pei, Xin-Qi, Tian, Ge, Wu, Da-Peng, Fan, Jin-Hai, Jiang, Yu-Mei, He, Da-Lin
Publicado no Asian J Androl (2018)

Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression

Por Wu, Kai-jie, Zeng, Jin, Zhu, Guo-dong, Zhang, Lin-lin, Zhang, Dong, Li, Lei, Fan, Jin-hai, Wang, Xin-yang, He, Da-lin
Publicado em 2009